Clinical nutrition by condition: what actually changes when you have a diagnosis

TL;DR. Once you have a diagnosis, "eat real food" gives way to medical nutrition therapy (MNT). MNT means specific food targets tied to your disease. The American Diabetes Association (ADA) accepted low-carb as a medical option for type 2 diabetes (T2D) in 2019. The DiRECT trial (Lean 2018) showed lasting T2D remission in primary care. For non-alcoholic fatty liver (NAFLD, now called MASLD), the first step is cutting fructose and losing 7 to 10 percent of body weight. For high blood pressure, the ratio of sodium to potassium beats sodium cuts alone. For chronic kidney disease (CKD), protein targets flip once you start dialysis. Gout's biggest food trigger is now fructose, not just purines. For irritable bowel syndrome (IBS), Monash University's low-FODMAP plan works in phases. For child Crohn's disease, exclusive enteral nutrition (EEN) is first-line. Celiac requires strict avoidance of gluten under 20 parts per million (ppm). PREDIMED (2013) is the strongest trial behind the Mediterranean diet. Eating-disorder recovery centers on refeeding-syndrome safety and ditching "good food / bad food" labels.

Important. This is education, not medical advice. MNT for any condition below must fit your other conditions, your medications (especially insulin, sulfonylureas, anticoagulants, diuretics, RAAS inhibitors, binders), pregnancy or breastfeeding, life stage, and food access. Ask your physician for a referral to a Registered Dietitian Nutritionist (RDN/RD). Look for one with the right board credential: CDCES for diabetes; CSR for kidney; CEDS-C / CEDRD for eating disorders; CSO for oncology. Your RDN writes the food plan, watches your labs, and adjusts as numbers change.

What you'll learn

• Carb counting in T2D and what the 2019 ADA shift on low-carb means.
• Why NAFLD/MASLD responds to less fructose and modest weight loss before drugs.
• Why the DASH (Dietary Approaches to Stop Hypertension) sodium-to-potassium ratio matters more than sodium alone.
• How CKD protein targets change once you start dialysis, and the pre-dialysis fluid-restriction myth.
• How fructose joined purines as a main food trigger for gout.
• The Monash low-FODMAP plan: cut, add back, personalize.
• Why EEN is first-line for child Crohn's, and where CDED and Mediterranean fit.
• What "gluten-free" means at 20 ppm. Celiac vs. NCGS vs. wheat allergy.
• Why PREDIMED is the strongest trial behind the Mediterranean diet.
• Why refeeding syndrome and ditching "good food / bad food" labels are non-negotiable.

1. Type 2 diabetes — carb counting and remission

T2D nutrition therapy follows the ADA's yearly Standards of Medical Care (Krause Ch 30, Jessica Jones). For non-pregnant adults, A1C target is under 7 percent. For older or sicker adults, it is under 8 percent. Pregnancy targets are tighter. Carb counting tracks the grams of carbs in a meal so insulin doses match. You use an insulin-to-carb ratio. This works because blood sugar after a meal is driven first by how many carbs you eat. Type of carb, fiber, fat, protein, and the order you eat foods come second.

The bigger story is the ADA's shift on cutting carbs. For decades it said 45 to 65 percent of calories from carbs. The 2019 ADA Consensus Report (Evert et al., Diabetes Care) accepted low-carb (under 26 percent) and very-low-carb or ketogenic (under 50 g/day) plans as evidence-supported options. Cutting carbs is now a medical option.

The remission case rests on two trials. The Newcastle 800-kcal very-low-calorie diet study (Lim et al., Diabetologia 2011) showed fast weight loss reversed pancreas and liver fat. It restored beta-cell function in people newly diagnosed with T2D. DiRECT (Lean et al., The Lancet 2018) extended this to UK primary care. 46 percent of patients in the program were in remission at one year. 36 percent were still in remission at two years (Lean 2019). Remission tracked weight loss. Hallberg et al. (Virta Health, Diabetes Therapy 2018) reported lasting reversal in 60 to 80 percent of patients on nutritional ketosis. Most stopped insulin.

Fasting insulin catches insulin resistance years before fasting glucose moves. Most physicians do not order it. A1C is misleading if you have conditions that change red blood cell turnover, such as hemoglobinopathies, recent transfusion, iron deficiency, or CKD. Eating disorders show up in diabetes too: diabulimia in type 1, binge eating disorder (BED) in T2. Screen for both. Ask for an RDN with the CDCES credential.

2. NAFLD / MASLD — fructose first, then weight loss

Non-alcoholic fatty liver disease was renamed metabolic dysfunction-associated steatotic liver disease (MASLD) in 2023. It has passed alcoholic liver disease as the most common chronic liver disease in the U.S. Krause Ch 29 (Hasse and Matarese) treats MASLD as the liver side of metabolic syndrome.

The biochemistry: almost all of the fructose you eat reaches the liver. It skips the phosphofructokinase brake on glycolysis. It drives fat creation in the liver (de novo lipogenesis). It also makes uric acid and methylglyoxal. Methylglyoxal damages tissues 250 times faster than glucose. The pathway looks a lot like ethanol. That is why Lustig calls fructose "the alcohol without the buzz."

First-line therapy is food, not drugs. Resmetirom got FDA approval in 2024 for biopsy-confirmed MASH with fibrosis. It is the first specific drug. Pioglitazone, vitamin E, and GLP-1 agonists have middle-tier evidence. All major guidelines call for 7 to 10 percent weight loss as the main step. At 10 percent, biopsy results improve more. Cutting added sugar (especially high-fructose corn syrup [HFCS] drinks) reduces liver fat within days. This happens before you see weight loss. The Mediterranean pattern has the strongest pattern-level evidence (Plaz Torres et al., Nutrients 2019). Lab markers to watch: ALT (the true upper limit is closer to 25 IU/L than the 40 most labs use), AST, GGT, FIB-4, FibroScan. Child MASLD is rising fast: up to 20 percent of U.S. kids. If you have active disease, skip alcohol.

3. Hypertension — DASH and the sodium-to-potassium ratio

DASH (Appel et al., NEJM 1997) is a food pattern rich in fruits, vegetables, whole grains, low-fat dairy, lean protein, nuts, and beans. In the trial, it dropped systolic blood pressure by 11.4 mmHg and diastolic by 5.5 mmHg in people with high blood pressure. That matches one blood pressure pill. DASH-Sodium (Sacks et al., NEJM 2001) showed extra benefit when sodium also went down.

The mechanism is not just less sodium. DASH is high in potassium (about 4,700 mg/day, equal to the Adequate Intake), magnesium, calcium, and fiber. Each of these on its own lowers blood pressure. The number to watch is the sodium-to-potassium ratio. Most U.S. adults eat about twice the Chronic Disease Risk Reduction (CDRR) target for sodium (3,400 vs. 2,300 mg). They eat about half the AI for potassium (2,500 vs. 4,700 mg). Fixing the ratio matters more than driving sodium toward zero. It is also easier to do. Add more potassium-rich foods: leafy greens, beans, lentils, sweet potato, banana, avocado, salmon, tomato. The ratio shifts without strict sodium rules.

Two warnings. Salt sensitivity varies. African Americans, older adults, and people with diabetes or CKD react more to sodium. In CKD and heart failure with RAAS blockers, potassium-rich foods may be unsafe. Lustig argues high insulin drives the kidney to hold onto sodium. The UK ran a processed-food sodium cap from 2006 to 2012. It is credited with about a 40 percent drop in stroke. The same approach to sugar would likely work at least as well.

4. Chronic kidney disease — protein, phosphate, and the fluid myth

CKD nutrition is one of the most complex MNT areas. Targets flip once you start dialysis. Krause Ch 35 (Wilkens, Shanaman, Juneja) and MNHD Ch 96 (Shah, Rhee, Kopple) are the references. CKD is staged by eGFR: Stage 3a is 45 to 59. Stage 3b is 30 to 44. Stage 4 is 15 to 29. Stage 5 is under 15 or on dialysis.

Before dialysis (Stages 3 to 5, not on dialysis), the protein target is 0.6 to 0.8 g/kg/day. Studies since MDRD show modest slowing of disease progression. The benefit is clearer in diabetic CKD. Plant-based protein (beans, soy, nuts) makes less acid for the kidney to clear than animal protein at the same intake. This is the basis of the PLADO pattern (plant-dominant). Phosphorus restriction is key. Inorganic phosphate additives in processed food (sodium phosphate, phosphoric acid in colas) are almost 100 percent absorbed. Organic phosphate in plants is 40 to 50 percent. In animal protein it is 60 to 70 percent. Phosphate binders (calcium acetate, sevelamer, lanthanum) trap food phosphate at meals. Potassium is restricted only when blood potassium is high. Cutting potassium by reflex blocks the foods DASH calls for.

On dialysis, protein targets jump. Hemodialysis: 1.2 g/kg/day. Peritoneal dialysis: 1.2 to 1.5 g/kg/day. Dialysate fluid washes out protein. Protein-energy wasting drives mortality. Adequacy markers: Kt/V (eKt/V at least 1.2), URR (at least 65 percent), nPNA (0.8 to 1.4 g/kg/day).

The pre-dialysis fluid-restriction myth: Stage 3 CKD patients often think they must limit fluids. If you are pre-dialysis and still making urine, drink to normal hydration (about 2 to 3 L/day). Restrict only if you have heart failure, edema, or low blood sodium. Fluid limits kick in once urine output drops and during dialysis (about 1 to 1.5 L/day plus your urine output). The myth probably comes from applying dialysis rules to earlier stages. Ask for an RDN with the CSR credential.

5. Gout — fructose joins purines

Gout was once treated as a purine-overload disease. The biochemistry is correct. Uric acid comes from purines via the xanthine oxidase enzyme. When blood uric acid passes about 6.8 mg/dL, urate crystals form in joints. But the food advice has changed.

Krause and current rheumatology now flag fructose as a main food trigger. Fructose sits alongside high-purine foods (organ meats, anchovies, sardines, mussels, beer) and alcohol. Mechanism: when the liver phosphorylates fructose, it uses up cell phosphate. AMP deaminase turns on. AMP gets shunted into uric acid via IMP and xanthine. Choi et al. (BMJ 2008; JAMA 2010) showed men who drank 2 or more sugar-sweetened beverages (SSBs) per day had 85 percent higher gout risk than men who drank under 1 per month. The risk held after accounting for meat and alcohol.

Practical food plan: cut SSBs and HFCS processed food to near zero. Trim but do not cut organ meats and oily fish (the omega-3s usually win the trade). Limit beer in particular (guanosine in beer drives uric acid more). Drink water. Aim for 5 to 10 percent weight loss, but slowly. Fast weight loss can set off flares. Take 500 mg/day of vitamin C; it modestly lowers uric acid. Low-fat dairy helps the kidney clear uric acid. Allopurinol or febuxostat are the standard xanthine oxidase inhibitors. Food is the add-on, not the main therapy.

6. IBS — Monash low-FODMAP cut and add-back

IBS (Rome IV criteria: belly pain at least 1 day per week with changes in stool form or frequency) affects about 10 percent of adults worldwide. The strongest food therapy is the low-FODMAP diet from Monash University (Shepherd, Muir, Gibson).

FODMAPs stand for Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols. Fructans (in wheat, onion, garlic) and galacto-oligosaccharides (GOS, in beans) are the oligos. Lactose is the disaccharide. Extra fructose (in honey, apples, mango, HFCS) is the monosaccharide. Polyols include sorbitol, mannitol, xylitol, and erythritol. The small intestine absorbs all four groups poorly. They pull water in and ferment fast in the colon.

The Monash plan has three phases. Cut phase (2 to 6 weeks): strict low-FODMAP using Monash serving-size limits. About 70 to 75 percent of patients feel relief (Halmos et al., Gastroenterology 2014; Marsh et al., Eur J Nutr 2016 meta-analysis). Add-back phase (6 to 8 weeks): challenge one FODMAP group at a time to find your triggers and your tolerance. Personalize phase: long-term diet that avoids only the groups that cause you symptoms.

The plan is not a forever diet. Long-term strict low-FODMAP eating drops helpful Bifidobacterium, narrows variety, and risks gaps in nutrition. Monash advises RDN supervision for both the cut and the add-back. Many patients get stuck in the cut phase. Other IBS therapies with evidence: psyllium, enteric-coated peppermint oil, gut-directed hypnotherapy, the Mediterranean pattern, strain-specific probiotics (Bifidobacterium infantis 35624). Ask for a Monash-certified RDN.

7. IBD (Crohn's, UC) — EEN for child Crohn's, then patterns

Inflammatory bowel disease (IBD) covers Crohn's disease and ulcerative colitis (UC). Both are chronic, relapsing autoimmune gut inflammation. They are not the same as IBS. Krause Ch 28 and MNHD Ch 80 (Limketkai, Parian, Mullin) treat IBD on its own. The mechanisms and food handles differ.

The most-cited food therapy is exclusive enteral nutrition (EEN) for child Crohn's. ESPGHAN, ECCO, and NASPGHAN guidelines list EEN as first-line for kids with mild-to-moderate Crohn's. It runs 6 to 8 weeks. Patients drink only polymeric or elemental formula. No solid food. Remission rates match steroids (60 to 80 percent). EEN skips the growth and bone side effects of steroids (Critch et al., JPGN 2012). EEN is less reliable in adults.

The Crohn's Disease Exclusion Diet (CDED) uses partial enteral nutrition. It removes foods thought to drive gut bacteria imbalance: animal fat, wheat, dairy, emulsifiers, and processed food. The Levine group's CDED trial (Gastroenterology 2019) showed child remission rates equal to EEN with better tolerance.

In UC, patterns are more about maintenance. The Mediterranean diet, the IBD-AID pattern (UMass), and cutting sulfur-reducing foods during flares all have backing. Sulfur-reducing bacteria make hydrogen sulfide. Hydrogen sulfide damages colon cells. Cutting red meat, eggs, and sulfur preservatives during flares is observational but reasonable.

In both diseases, watch for nutrient gaps. Iron deficiency anemia hits most patients at some point. B12 drops with terminal-ileal Crohn's or after gut resection. Vitamin D, calcium, magnesium, and zinc drop with diarrhea. Bile-acid malabsorption shows up in terminal-ileal disease. Ask for an RDN with IBD experience.

8. Celiac disease — what gluten-free actually means

Celiac disease is a T-cell autoimmune gut disease set off by gluten. Gluten comes as gliadin in wheat, hordein in barley, and secalin in rye. You need HLA-DQ2 or DQ8 genes. About 1 percent of people have it. Screening is anti-tTG IgA plus total IgA plus anti-DGP. Biopsy confirms. Krause Ch 28 and MNHD Ch 81 (Hakimian and Semrad) cover the food plan.

Three terms get mixed up:

• Celiac disease is autoimmune. Gluten flattens the gut villi. You malabsorb, and complications follow: anemia, osteoporosis, infertility, enteropathy-associated T-cell lymphoma (EATL). Treatment is lifelong, strict, total gluten avoidance.
• Non-celiac gluten sensitivity (NCGS) means you feel better on a gluten-free diet (GFD) but have no celiac serology, no biopsy damage, and no wheat IgE. Some patients may actually react to fructans (FODMAPs), not gluten (Biesiekierski et al.).
• Wheat allergy is IgE-mediated. It causes hives, anaphylaxis, or exercise-induced anaphylaxis. You avoid wheat (not all gluten grains) and carry an epinephrine pen.

For celiac, "gluten-free" in the U.S. is a regulatory term. The FDA defines a product as gluten-free if it contains under 20 parts per million (20 ppm) of gluten. That is not zero. 20 ppm is the detection floor of the ELISA tests used. It matches Codex Alimentarius and the EU. Patients who still have symptoms may need to go under 20 ppm by avoiding shared production lines. At home, cross-contact (shared toasters, cutting boards, deep fryers, condiment jars) is the most common reason guts fail to heal.

Practical food plan: avoid wheat, barley, rye, malt, brewer's yeast, and most beers. Watch hidden gluten in soy sauce, modified food starch, and communion wafers. Replace with rice, corn, certified gluten-free oats, pseudocereals (quinoa, amaranth, buckwheat, millet, teff), and beans. Monitor iron, B12, folate, vitamin D, calcium, and zinc during healing. Recheck serology every 6 to 12 months. Villi heal in 1 to 5 years on strict avoidance. Ask for an RDN with celiac experience.

9. Cardiovascular disease — PREDIMED and the Mediterranean pattern

PREDIMED (Prevención con Dieta Mediterránea; Estruch et al., NEJM 2013, retracted and republished 2018 with corrected stats that did not change the conclusions) is the strongest randomized trial behind any food pattern for heart disease prevention. It enrolled 7,447 Spanish adults at high heart risk. The trial randomized them to one of three groups. Group 1: Mediterranean plus extra-virgin olive oil (EVOO, about 50 g/day). Group 2: Mediterranean plus mixed nuts (about 30 g/day). Group 3: low-fat control. The two Mediterranean arms cut the primary endpoint (heart attack, stroke, heart death) by about 30 percent over a median 4.8 years. The trial stopped early for benefit. Substudies showed gains in thinking skills, breast cancer (EVOO arm), peripheral artery disease, and atrial fibrillation.

The PREDIMED pattern (Krause Appendix 22, MNHD Ch 67 Schaefer): EVOO as the main cooking fat. 7 to 10 servings of fruit and vegetables daily. Beans 3 or more times per week. Whole grains. Fatty fish 3 or more times per week. Nuts daily. Moderate red wine with meals (with the note that "no alcohol" is a cleaner public health message). Little red and processed meat. Little added sugar and ultra-processed food.

The 50 g/day EVOO dose is higher than most U.S. patients use. It helps explain why PREDIMED's effect size is so big. Olive oil's MUFA (oleic acid) and polyphenols (hydroxytyrosol, oleocanthal) are biologically active. Extra-virgin is not the same as refined. The earlier Lyon Diet Heart Study (de Lorgeril et al., The Lancet 1994) tested secondary prevention in post-heart-attack patients. It showed a 50 to 70 percent drop in cardiovascular events and deaths. PREDIMED's larger size and primary-prevention design make it the more-cited reference.

For dyslipidemia: soluble fiber (10 to 25 g/day psyllium-equivalent) cuts LDL 5 to 10 percent. Plant sterols (2 g/day) cut LDL about 10 percent. Trans fat was banned from the U.S. food supply in 2018. The advanced lipid panel (ApoB, NMR fractionation, Lp(a)) gives a sharper picture than total LDL-C. Small-dense LDL (type B) is the harmful kind. It tracks better with refined carbs than with saturated fat.

10. Eating-disorder recovery — refeeding syndrome and no "good food / bad food"

Eating disorders include anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), other specified feeding or eating disorder (OSFED), and avoidant/restrictive food intake disorder (ARFID). All are mental illnesses with medical complications that can be fatal. AN has the highest death rate of any mental illness (5 to 15 percent long-term). Krause Ch 22 (Schebendach and Roth, Columbia / NYSPI) and MNHD Ch 95 are the clinical references.

The first concern in nutrition rehab is refeeding syndrome. This is what happens when you feed a starved patient too fast. Long starvation drops phosphate, potassium, and magnesium inside cells. Blood levels can still look normal. Then food triggers insulin. Insulin drives those electrolytes into cells. Blood levels then drop fast. Low phosphate is the main feature. It can cause heart failure (the heart needs phosphate for ATP), lung failure, hemolysis, muscle breakdown (rhabdomyolysis), seizures, and death. Carbs also raise the need for thiamine. That can expose a deficiency and cause Wernicke encephalopathy.

Prevention: spot high-risk patients. The signs are BMI under 14, weight loss over 15 percent in 3 months, long fasting, or alcohol use disorder. Start slow: often 10 to 20 kcal/kg/day for 24 hours. Then add 200 to 300 kcal/day each day across the first week. Give thiamine (100 to 300 mg/day) before the first feeding. Add a B-complex or multivitamin. Check phosphate, potassium, and magnesium each day during the first week. Replace as needed. Current guidelines (NICE, ASPEN) say to start nutrition with close monitoring rather than hold it back. Once stable, teen AN inpatients in weight restoration often need 3,000 to 4,000 kcal/day.

The second non-negotiable is no "good food / bad food" framing. Patients with eating disorders often arrive with rigid binary labels: clean/dirty, safe/unsafe, healthy/forbidden. The disorder feeds on these labels. Reinforcing the binary keeps the disease alive. Even pushing "healthier" choices can do harm. The RDN's job is to widen variety, lower food anxiety, set steady eating times, separate hunger and fullness from emotion, and bring fear foods back in. This clashes with much popular nutrition messaging, including parts of this article series for non-ED readers. The clinical RDN adapts.

Family-Based Therapy (FBT, Maudsley) for teen AN gives parents control over meal planning. The RDN consults rather than counsels the patient directly. CBT-E, classic CBT, and DBT are the main therapy frames. Drug therapy is limited. SSRIs help paired anxiety or depression. Lisdexamfetamine helps BED. Olanzapine helps severe AN. Ask for a CEDS-C, CEDRD, or AED-member clinician. Recovery takes a team.

Frequently Asked Questions

Should I see a Registered Dietitian Nutritionist (RDN) or an "RD"?

Same credential. The Academy of Nutrition and Dietetics added "Nutritionist" to "Registered Dietitian" in 2013. Both names mean a clinician who finished a CDR-accredited program, supervised practice, and the CDR exam. They are licensed in 47 of 50 U.S. states. "Nutritionist" on its own is not a protected title. For specialty conditions, look for these letters after the name: CDCES (diabetes), CSR (kidney), CEDS-C or CEDRD (eating disorders), CSO (oncology), CNSC (nutrition support), CSP (pediatrics).

What is medical nutrition therapy (MNT)?

MNT is the structured nutrition treatment of a medical condition by an RDN. It runs on the Nutrition Care Process. The steps are assessment, nutrition diagnosis (PES statement: Problem, Etiology, Signs and Symptoms), intervention, and monitoring with evaluation. RDNs use the Academy's standardized terms (eNCPT). Medicare Part B covers MNT for diabetes, CKD, and post-kidney-transplant care under set visit limits.

Is keto a "medical diet"?

For T2D, the 2019 ADA Consensus Report accepts very-low-carb or ketogenic patterns as evidence-supported options. For drug-resistant child epilepsy, the ketogenic diet has been a medical treatment for decades. Variants include classical 4:1, MCT, modified Atkins, and low-GI. For Alzheimer's, glioma, polycystic ovary syndrome (PCOS), and NAFLD, evidence looks promising but is not yet firm. If you take insulin or sulfonylureas and try keto without changing your meds, you can drop into severe low blood sugar within days. This needs clinician supervision.

Food allergy vs. food intolerance vs. food sensitivity?

Food allergy is immune-mediated, usually IgE. It is acute and can cause anaphylaxis. The 9 major U.S. allergens are milk, egg, peanut, tree nut, soy, wheat, fish, shellfish, and sesame (added 2023). Diagnosis uses history, skin-prick, specific IgE, and sometimes oral challenge. Food intolerance is not immune. It comes from enzyme gaps (lactase, sucrase-isomaltase) or drug-like effects (caffeine, histamine, FODMAPs). It is dose-dependent and not life-threatening. Food sensitivity is a vague term in casual use. IgG testing for "food sensitivity" is rejected by AAAAI and EAACI. A positive IgG just means you have been exposed. It does not mean you have a disease.

Is intermittent fasting evidence-based for T2D?

Moderate evidence. Time-restricted eating (TRE, an 8 to 10-hour eating window) improves blood sugar markers. Effects are stronger when the window is earlier in the day. Sutton et al. (Cell Metabolism 2018) showed early TRE improved insulin sensitivity, blood pressure, and oxidative stress even without weight loss. Patients on insulin or sulfonylureas need a medication change. The risk of low blood sugar goes up. People who are pregnant, breastfeeding, have a history of eating disorders, or have type 1 diabetes should not do long fasts without a specialist.

Are probiotic supplements clinically useful?

Strain-specific, condition-specific, and modest. Per ISAPP (International Scientific Association for Probiotics and Prebiotics), "probiotic" is not a category-level claim. Specific strains have specific evidence. Bifidobacterium infantis 35624 helps IBS. Saccharomyces boulardii helps antibiotic-associated diarrhea and recurring C. difficile infections. Lactobacillus rhamnosus GG helps acute infectious diarrhea in kids. Multi-strain VSL#3 or Visbiome prevents pouchitis. For most people without a specific reason, fermented foods (yogurt, kefir, sauerkraut, kimchi, miso) have stronger evidence than capsules.

Why does this article keep saying "see an RDN"?

Because MNT must be tailored to you. Targets like "0.6 to 0.8 g/kg protein for pre-dialysis CKD" or "20 ppm gluten threshold for celiac" are population-level. They need translation into your foods, your other conditions, your medications, and your life stage. An RDN is trained to translate, monitor, and adjust. This article helps you see what your RDN is doing, and notice when something doesn't add up.

What if my physician doesn't refer me?

Ask. In many states, Medicare Part B covers MNT for diabetes and CKD without a referral. Commercial insurance varies. The Academy of Nutrition and Dietetics's Find a Nutrition Expert directory lists credentialed RDNs. Condition-specific groups (Celiac Disease Foundation, Crohn's & Colitis Foundation, IAEDP) keep lists too. Telehealth has expanded access since 2020.

Sources

1. Lean, M. E. J., Leslie, W. S., Barnes, A. C., et al. "Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial." The Lancet, 2018;391(10120):541–551. Two-year follow-up: Lancet Diabetes & Endocrinology, 2019;7(5):344–355.
2. Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., et al. "Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol." Diabetologia, 2011;54(10):2506–2514. Newcastle 800-kcal study.
3. Evert, A. B., Dennison, M., Gardner, C. D., et al. "Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report." Diabetes Care, 2019;42(5):731–754. ADA formal recognition of low-carbohydrate options.
4. Hallberg, S. J., McKenzie, A. L., Williams, P. T., et al. "Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year." Diabetes Therapy, 2018;9(2):583–612. Virta Health.
5. Appel, L. J., Moore, T. J., Obarzanek, E., et al. "A clinical trial of the effects of dietary patterns on blood pressure." NEJM, 1997;336(16):1117–1124. DASH.
6. Sacks, F. M., Svetkey, L. P., Vollmer, W. M., et al. "Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet." NEJM, 2001;344(1):3–10.
7. Estruch, R., Ros, E., Salas-Salvadó, J., et al. "Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts." NEJM, 2018;378(25):e34 (retracted and republished from 2013). PREDIMED.
8. de Lorgeril, M., Renaud, S., Mamelle, N., et al. "Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease." The Lancet, 1994;343(8911):1454–1459. Lyon Diet Heart Study.
9. Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., Muir, J. G. "A diet low in FODMAPs reduces symptoms of irritable bowel syndrome." Gastroenterology, 2014;146(1):67–75. Monash low-FODMAP RCT.
10. Marsh, A., Eslick, E. M., Eslick, G. D. "Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders?" European Journal of Nutrition, 2016;55(3):897–906.
11. Levine, A., Wine, E., Assa, A., et al. "Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial." Gastroenterology, 2019;157(2):440–450.
12. Critch, J., Day, A. S., Otley, A., et al. "Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease." JPGN, 2012;54(2):298–305. EEN guidelines.
13. Choi, H. K., Willett, W., Curhan, G. "Fructose-rich beverages and risk of gout in women." JAMA, 2010;304(20):2270–2278. See also Choi & Curhan, BMJ, 2008;336:309–312 (men).
14. Sutton, E. F., Beyl, R., Early, K. S., et al. "Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes." Cell Metabolism, 2018;27(6):1212–1221.
15. Raymond, J. L., Morrow, K., eds. Krause and Mahan's Food and the Nutrition Care Process, 16th edition. Elsevier, 2023. Esp. Ch 22 (Schebendach & Roth, eating disorders), 28 (lower GI), 29 (Hasse & Matarese, hepatobiliary), 30 (Jones, diabetes), 33 (cardiovascular), 35 (Wilkens et al., renal).
16. Tucker, K. L., Duggan, C. P., Jensen, G. L., et al., eds. Modern Nutrition in Health and Disease, 12th edition. Jones & Bartlett, 2026 imprint. Esp. Ch 67 (Schaefer, lipoprotein), 68 (Andries et al., BP), 80 (Limketkai et al., IBD), 81 (Hakimian & Semrad, celiac), 95 (eating disorders), 96 (Shah et al., kidney).
17. Gropper, S. S., Smith, J. L., Carr, T. P. Advanced Nutrition and Human Metabolism, 8th edition. Cengage, 2022. Pathway biochemistry underlying MNT.
18. Lustig, R. H. Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine (2021). Fructose-as-ethanol biochemistry; hyperinsulinemia and renal sodium retention.
19. Means, C., with Means, C. Good Energy: The Surprising Connection Between Metabolism and Limitless Health (2024). Pediatric NAFLD prevalence; fasting insulin and HOMA-IR.
20. ISAPP. Hill, C., Guarner, F., Reid, G., et al. "Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic." Nature Reviews Gastroenterology & Hepatology, 2014;11(8):506–514.

Related glossary terms

• MNT (medical nutrition therapy)
• Carb counting
• DASH diet
• Low-FODMAP
• Gluten-free
• Mediterranean diet
• CKD stage
• NAFLD
• Gout
• IBD
• IBS
• Celiac